Vijaya Diagnostic Centre Limited (NSE:VIJAYA) — Market Cap & Net Worth
Market Cap & Net Worth: Vijaya Diagnostic Centre Limited (VIJAYA)
Vijaya Diagnostic Centre Limited (NSE:VIJAYA) has a market capitalization of $1.45 Billion (Rs134.34 Billion) as of June 19, 2026. Listed on the NSE stock exchange, this India-based company holds position #7507 globally and #360 in its home market, demonstrating a 2.83% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Vijaya Diagnostic Centre Limited's stock price Rs1305.60 by its total outstanding shares 102896728 (102.90 Million). Review Vijaya Diagnostic Centre Limited total liabilities to assess the company's total debt and financial obligations.
Vijaya Diagnostic Centre Limited Market Cap History: 2021 to 2026
Vijaya Diagnostic Centre Limited's market capitalization history from 2021 to 2026. Data shows growth from $644.49 Million to $1.45 Billion (17.07% CAGR).
Index Memberships
Vijaya Diagnostic Centre Limited is a constituent of 4 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY 500
NIFTY500
|
$3.15 Trillion | 0.05% | #302 of 500 |
|
NIFTY MIDSMALLCAP 400
NIFTYMIDSML400
|
$1.15 Trillion | 0.13% | #212 of 400 |
|
NIFTY TOTAL MARKET
NIFTYTOTALMKT
|
$3.24 Trillion | 0.04% | #310 of 750 |
|
NIFTY SMALLCAP 250
NISM250
|
$390.05 Billion | 0.37% | #116 of 250 |
Weight: Vijaya Diagnostic Centre Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Vijaya Diagnostic Centre Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Vijaya Diagnostic Centre Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.18x
Vijaya Diagnostic Centre Limited's market cap is 0.18 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.84x
Vijaya Diagnostic Centre Limited's market cap is 0.84 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $644.49 Million | $3.76 Billion | $844.78 Million | 0.17x | 0.76x |
| 2022 | $484.89 Million | $4.62 Billion | $1.10 Billion | 0.10x | 0.44x |
| 2023 | $751.07 Million | $4.59 Billion | $846.32 Million | 0.16x | 0.89x |
| 2024 | $1.18 Billion | $5.48 Billion | $1.19 Billion | 0.21x | 0.99x |
| 2025 | $1.18 Billion | $6.81 Billion | $1.43 Billion | 0.17x | 0.83x |
| 2026 | $1.45 Billion | $8.14 Billion | $1.73 Billion | 0.18x | 0.84x |
Competitor Companies of VIJAYA by Market Capitalization
Companies near Vijaya Diagnostic Centre Limited in the global market cap rankings as of June 19, 2026.
Key companies related to Vijaya Diagnostic Centre Limited by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #131 globally with a market cap of $174.56 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #189 globally with a market cap of $125.14 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #621 globally with a market cap of $44.18 Billion USD.
- LONZA GROUP UNSP.ADR 1/10 (F:LO3A): Ranked #664 globally with a market cap of $41.04 Billion USD ( €35.10 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #131 | Thermo Fisher Scientific Inc | NYSE:TMO | $174.56 Billion | $464.61 |
| #189 | Danaher Corporation | NYSE:DHR | $125.14 Billion | $177.17 |
| #621 | IDEXX Laboratories Inc | NASDAQ:IDXX | $44.18 Billion | $562.09 |
| #664 | LONZA GROUP UNSP.ADR 1/10 | F:LO3A | $41.04 Billion | €54.50 |
Vijaya Diagnostic Centre Limited Historical Marketcap From 2021 to 2026
Between 2021 and today, Vijaya Diagnostic Centre Limited's market cap moved from $644.49 Million to $ 1.45 Billion, with a yearly change of 17.07%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs1.45 Billion | +23.05% |
| 2025 | Rs1.18 Billion | +0.39% |
| 2024 | Rs1.18 Billion | +56.58% |
| 2023 | Rs751.07 Million | +54.90% |
| 2022 | Rs484.89 Million | -24.76% |
| 2021 | Rs644.49 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 19th, 2026 the market cap of Vijaya Diagnostic Centre Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.45 Billion USD |
| MoneyControl | $1.45 Billion USD |
| MarketWatch | $1.45 Billion USD |
| marketcap.company | $1.45 Billion USD |
| Reuters | $1.45 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Vijaya Diagnostic Centre Limited
Vijaya Diagnostic Centre Limited provides diagnostic services for patients in India. The company offers laboratory services, including clinical pathology, microbiology, haematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics, CT scan, magnetic resonance imaging (MRI) scan, ultrasound, X-ray, cardiology, gastroenterology, nuclear medicine and PET/CT, and MRI-3T ser… Read more